RxDoctor Payments Data

Suzanne Araujo

Family · Land O Lakes, FLNPI 1417620386

Payments from drug & device makers

$2,425in general payments, 2019–2025

Across 123 payments — averaging $19.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$381
  • AstraZeneca$326
  • Novo Nordisk$223
  • Otsuka America Pharmaceutical, Inc.$177
  • Sanofi-aventis U.S. LLC$153
  • Xeris Pharmaceuticals, Inc.$146
  • plus $1K from 18 others

What the payments were for

  • Food & beverage$2,425100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,425 in reported general payments places this provider in the 85th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin128$141,136
EliquisApixaban43$37,846
JanuviaSitagliptin Phosphate14$20,207
OzempicSemaglutide16$17,511
Fluticasone-SalmeterolFluticasone Propion/Salmeterol33$9,196
XareltoRivaroxaban16$9,071
Spiriva RespimatTiotropium Bromide18$8,984
Lantus SolostarInsulin Glargine,hum.Rec.Anlog65$7,573
Tresiba Flextouch U-100Insulin Degludec11$6,459
SymbicortBudesonide/Formoterol Fumarate20$5,136
Albuterol Sulfate HfaAlbuterol Sulfate139$3,504
Gabapentin158$3,287
Levothyroxine Sodium181$3,097
Atorvastatin Calcium425$2,965
Wixela InhubFluticasone Propion/Salmeterol14$2,704

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat$54$150,120146 claims
PfizerEliquis$62$37,84643 claims
MerckJanuvia$65$20,20714 claims
Novo NordiskOzempic$223$17,51116 claims
AstraZenecaSymbicort$326$5,13620 claims
Sanofi-aventis U.S. LLCLantus$153$2,53718 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 14,618 family providers in Florida.

Other family in Land O Lakes

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →